Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JonB
    Member
    • Jan 2010
    • 85

    Mixing paired-end and single-end reads in Tophat: Do I have to reverse the SE-reads f

    This is a cross-post from the Tuxedo Google group: https://groups.google.com/forum/#!to...rs/BtI3_fp_n-o

    And a follow-up from a previous post


    Hope my question makes sense. I have paired-end reads, but after trimming some reads are left as single-end. I know that tophat can take a mix of paired-end and single-end reads, but do I have to reverse the single-end reads from the rightmost pair (usually called the R2-file or something similar) if they have no mate?

    Thanks,

    Jon
  • SylvainL
    Senior Member
    • Feb 2012
    • 180

    #2
    Not sure I understood, but all the reads are from 5' to 3' so you should not have to reverse the SE...

    Comment

    • JonB
      Member
      • Jan 2010
      • 85

      #3
      The paired reads are sequenced like this
      R1------> <------R2
      and I guess tophat takes this into account when it is fed paired reads. But when it only gets the R2 reads as single end, without knowing that they were part of a pair, will it still be ok?

      Comment

      • SylvainL
        Senior Member
        • Feb 2012
        • 180

        #4
        If your R1 read is mapping to the forward strand, then the R2 will map to the reverse one...

        Actually, the only interest to reverseComplement (not only reverse) would be if you did stranded RNAseq... but even in this case, if you map separately only the R2 reads, you can simply change the strand afterwards...

        Comment

        • JonB
          Member
          • Jan 2010
          • 85

          #5
          I should have mentioned that I do have stranded sequencing. So I guess I will map the R2 reads separately.
          Thanks!

          Comment

          • SylvainL
            Senior Member
            • Feb 2012
            • 180

            #6
            Ok, then it makes sense to reverseComplement (or easiest, as mentioned, is to change the strand after the mapping for R2 alone...)...
            Actually, maybe to confuse you a bit more, the R2 (without reverseComplementing them, or witghout changing the strand after mapping), will be on the same strand than your gene (the coding sequence). R1 will be in the opposite one

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            29 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            211 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            78 views
            0 reactions
            Last Post SEQadmin2  
            Working...